Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI for Screening and Monitoring Systemic Sclerosis Interstitial Lung Disease

NCT05204355 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT05204355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05204355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI for Screening and Monitoring Systemic Sclerosis Interstitial Lung Disease
Lead sponsor
University of Kansas Medical Center
Phase
Observational
Overall status
Completed
Start date
May 1, 2022
Completion date
October 31, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma